Renaissance Technologies - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 55 filers reported holding TSCAN THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$468,000
+125369.2%
80,000
+70.2%
0.00%0.0%
Q1 2024$373
+193.7%
47,000
+116.6%
0.00%
Q4 2023$127
+182.2%
21,700
+22.6%
0.00%
Q3 2023$45
-87.8%
17,700
-88.0%
0.00%
-100.0%
Q2 2023$369
+1437.5%
147,462
+1171.2%
0.00%
Q1 2023$24
+50.0%
11,600
+16.0%
0.00%
Q4 2022$16
-100.0%
10,000
-24.8%
0.00%
Q1 2022$37,00013,3000.00%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
DC Funds, LP 630,000$3,685,50061.20%
Lynx1 Capital Management LP 5,224,600$30,563,91011.03%
Propel Bio Management, LLC 2,087,139$12,209,7637.92%
Deer Management Co. LLC 1,245,504$7,286,1981.50%
STEMPOINT CAPITAL LP 845,069$4,943,6541.45%
GREAT POINT PARTNERS LLC 940,831$5,503,8611.05%
EcoR1 Capital, LLC 5,000,000$29,250,0000.90%
BVF INC/IL 2,989,474$17,488,4230.49%
Simplify Asset Management Inc. 1,046,916$6,124,4590.41%
Alphabet Inc. 1,077,080$6,300,9180.32%
View complete list of TSCAN THERAPEUTICS INC shareholders